A wave of hospital chains and IVF companies in India are gearing up for a significant public offering worth around ₹20,000 crore in 2026, driven by strong fundamentals and favorable market conditions.

In 2025, the Central Govt Health Scheme (CGHS) empanelled 468 hospitals, marking significant expansion across India despite ...

The Bombay High Court calls for collective responsibility in addressing Mumbai's air pollution crisis while the BMC outlines ...

A new study suggests that normalizing blood glucose levels through lifestyle changes can significantly reduce the risk of ...

The ICMR has funded the IPIROC study to evaluate a cost-effective dosing strategy for PARP inhibitor rucaparib in ovarian cancer patients, aiming to enhance access and reduce side effects.

A recent study by The George Institute and Imperial College London highlights the exclusion of women from heat adaptation ...

Arogya World honored 41 organizations for outstanding employee wellbeing initiatives at the 2025 Global Summit, emphasizing ...

Israeli and Dutch researchers develop FibrilPaint and FibrilRuler to measure Tau amyloid fibrils in real-time, potentially revolutionizing Alzheimer's diagnostics and drug development.

AIIMS New Delhi successfully led India's first clinical trial of the Supernova stent retriever, demonstrating effective and ...

Explore the rising prevalence of weight-loss drugs in India, their impact on health and wellness, and the critical balance needed between medication and lifestyle interventions in managing obesity.

The Rajendra Institute of Medical Sciences (RIMS) building is in a state of severe disrepair, causing safety concerns for patients and staff. Immediate attention is required as structural issues ...

AIIMS New Delhi successfully conducted India's first clinical trial for an indigenously developed advanced stroke device, the ...